A recent gathering of pharmaceutical leaders featured discussions on artificial intelligence adoption. The event included keynotes and panel discussions, with a significant increase in participation from the previous year. Decision makers and sponsors made up a substantial portion of attendees.

The summit's speaker lineup was notable, with former US officials and other prominent figures participating. Further details about the event are available from the source.

A total of over 120 senior leaders attended, with a focus on transformation within the life sciences sector.